Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery
- 1 July 1991
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 85 (1) , 137-142
- https://doi.org/10.1111/j.1365-2249.1991.tb05694.x
Abstract
SUMMARY: After trauma, inflammatory, immunological and hormonal changes are well documented. Surgical intervention is a form of programmed trauma. Through the study of surgical patients, changes in early endogenous mediators of inflammation, immune response and tissue repair can be investigated. Here we analysed changes in serum levels of IL-1 inhibitors, IL-1β, IL-6, tumour necrosis factor-alpha (TNF-α) and cortisol in patients undergoing elective surgery. C-reactive protein (CRP) was measured as a marker of the acute-phase response. Rises in serum levels of IL-1 inhibitors. IL-6 and cortisol were detected as early as 1 h after the intervention. Peak levels were reached between 2 and 5 h. Serum levels of IL-6 and cortisol remained elevated for several days implying a persistent production. Serum levels of IL-1 and TNF did not change after the intervention. CRP levels peaked on day 2. The communication system sustained by endogenous mediators is activated after surgery as shown by selective changes in IL-1 inhibitors, IL-6 and cortisol. These mediators have different kinetics in serum and IL-6 is not the only early mediator detected. Some IL-1 inhibitors might be involved in the immunological depression observed after major surgery, in the regulation of the inflammatory response or in tissue repair. IL-6 and cortisol seem to act synergistically to activate the acute-phase response. A systemic role for IL-l and TNF is not evident, even if the possibility that these lymphokines may act locally is not ruled out.Keywords
This publication has 19 references indexed in Scilit:
- Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.Journal of Clinical Investigation, 1990
- Interleukin-6: An OverviewAnnual Review of Immunology, 1990
- Fate of interleukin‐6 in the ratEuropean Journal of Biochemistry, 1990
- Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin FeverThe Journal of Infectious Diseases, 1990
- Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operationClinical Immunology and Immunopathology, 1989
- Native interleukin 1 inhibitorsImmunology Today, 1989
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSESThe Lancet, 1987
- Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.Journal of Clinical Investigation, 1986
- Demonstration of Circulating Leukocytic Pyrogen/Interleukin-1 during FeverNew England Journal of Medicine, 1984